Alpha Tau Medical (DRTS) Retained Earnings (2020 - 2026)
Alpha Tau Medical (DRTS) posted Retained Earnings of -$213.1 million for Q1 2026, down 12.06% sequentially from -$190.1 million in Q4 2025, and down 36.41% YoY from -$335.1 million in Q1 2025.
Alpha Tau Medical (DRTS) Retained Earnings (2020 - 2026) Analysis & Trends
Alpha Tau Medical has reported Retained Earnings for 7 years, with the latest figure at -$213.1 million in Q1 2026.
- Quarterly Retained Earnings fell 36.41% year-over-year to -$213.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$213.1 million (down 36.41% YoY) and the FY2025 annual result came in at -$190.1 million, down 28.9% from the prior year.
- Retained Earnings declined to -$213.1 million in Q1 2026 per DRTS's latest filing, from -$190.1 million in the prior quarter.
- Over five years, Retained Earnings peaked at -$78.6 million in Q1 2022 and troughed at -$213.1 million in Q1 2026.
- A 5-year average of -$129.1 million and a median of -$123.7 million in 2024 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2022 and 2023: Retained Earnings sank 63.89% in 2022, then decreased 20.62% in 2023.
- Over 5 years, Retained Earnings stood at -$86.6 million in 2022, then tumbled by 33.67% to -$115.8 million in 2023, then retreated by 27.43% to -$147.5 million in 2024, then slipped by 28.9% to -$190.1 million in 2025, then declined by 12.06% to -$213.1 million in 2026.
- According to Business Quant data, Retained Earnings over the past three periods registered -$213.1 million, -$190.1 million, and -$178.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -4.00 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 13.05 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -104.13 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 4.38 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -6.33 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.57 Bn |
| 10 | Alpha Tau Medical | 1.32 Bn | 1.32 Bn | - | -258.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -258.89 Mn |
| Mar 31, 2026 | -213.08 Mn |
| Dec 31, 2025 | -190.14 Mn |
| Sep 30, 2025 | -178.00 Mn |
| Jun 30, 2025 | -166.31 Mn |
| Mar 31, 2025 | -156.20 Mn |
| Dec 31, 2024 | -147.51 Mn |
| Sep 30, 2024 | -138.03 Mn |
| Jun 30, 2024 | -131.11 Mn |
| Mar 31, 2024 | -123.74 Mn |
| Dec 31, 2023 | -115.76 Mn |
| Sep 30, 2023 | -108.39 Mn |
| Jun 30, 2023 | -103.48 Mn |
| Mar 31, 2023 | -94.79 Mn |
| Dec 31, 2022 | -86.60 Mn |
| Sep 30, 2022 | -83.21 Mn |
| Jun 30, 2022 | -80.58 Mn |
| Mar 31, 2022 | -78.58 Mn |
| Dec 31, 2021 | -52.84 Mn |
| Dec 31, 2020 | -25.57 Mn |